Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

H Lundbeck A/S

+ Add to Watchlist

LUN:DC

134.3000 DKK 0.1000 0.07%

As of 08:54:04 ET on 01/29/2015.

Snapshot for H Lundbeck A/S (LUN)

Open: 134.0000 Day's Range: 132.7000 - 134.3000 Volume: 134,825
Previous Close: 134.2000 52wk Range: 111.5000 - 173.6000 1-Yr Rtn: +1.57%

Stock Chart for LUN

No chart data available.
  • LUN:DC 134.8000
  • 1D
  • 1M
  • 1Y
134.2000
Interactive LUN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LUN

Current P/E Ratio (ttm) 52.0795
Estimated P/E(12/2014) 40.8425
Relative P/E vs. KFX 2.3618
Earnings Per Share (DKK) (ttm) 2.5672
Est. EPS (DKK) (12/2014) 3.2760
Est. PEG Ratio -
Market Cap (M DKK) 26,257.19
Shares Outstanding (M) 196.39
30 Day Average Volume 136,130
Price/Book (mrq) 1.8937
Price/Sale (ttm) 1.9128
Dividend Indicated Gross Yield 2.07%
Cash Dividend (DKK) 2.7700
Dividend Ex-Date 03/27/2014
5 Year Dividend Growth 3.79%
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LUN

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for LUN

H. Lundbeck A/S is an international pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of psychiatric and neurological disorders. The Company focuses on mood disorders, dementia, anxiety, and sleep disorders. Lundbeck does research both in-house and in cooperation with research centers. The Company markets its products worldwide.

Anders GotzscheExec VP/CFOAnders Gersel PedersenExec VP:Research & Dev
Jorn MayntzhusenSenior Mgr:Supply OptimisationPalle Holm OlesenHead:Investor Relations
More Company Profile & Key Executives for LUN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil